A Rare TNNT1 Gene Variant Causing Creatine Kinase Elevation in Nemaline Myopathy: C.271_273del (p.Lys91del)

Overview

Journal Genes Genomics

Specialty Genetics

Date 2024 Feb 16

PMID 38363456

Authors

Cuneyd Yavas

Mustafa Dogan

Recep Eroz

Kubra Turegun

Affiliations

Soon will be listed here.

Abstract

Background: Nemaline Myopathy (NM) is a rare genetic disorder that affects muscle function and is characterized by the presence of nemaline rods in muscle fibers. These rods are abnormal structures that interfere with muscle contraction and can cause muscle weakness, respiratory distress, and other complications. NM is caused by variants in several genes, including TNNT1, which encodes the protein troponin T1. NM is inherited in an autosomal recessive pattern. The prevalence of heterozygous TNNT1 variants has been reported to be 1/152,000, indicating that the disease is relatively rare.

Objective: Investigation of TNNT1 gene variants that may cause cretin kinase elevation.

Methods: Detailed family histories and clinical data were recorded. Whole exome sequencing was performed and family segregation was done by Sanger sequencing.

Results: In this study, we report a 5-year-old girl with a novel variant recessive congenital TNNT1 myopathy. The patient had a novel homozygous (c.271_273del) deletion in the TNNT1 gene that is associated with creatine kinase elevation, which is a marker of muscle damage.

Conclusion: This case expands the phenotypic spectrum of TNNT1 myopathy and highlights the importance of genetic testing and counseling for families affected by this rare disorder. In this study provides valuable insights into the genetic basis of NM and highlights the importance of early diagnosis and management for patients with this rare disorder. Further research is needed to better understand the pathophysiology of TNNT1 myopathy and to develop effective treatments for this debilitating condition.

Citing Articles

The Evaluation of the Genetic Variation Types of the Gene by Next-Generation Sequencing and Their Effects on Bilirubin Levels in Obese Children.

Aslantas M, Kilicaslan O, Eroz R, Kocabay K Genet Test Mol Biomarkers. 2024; 28(7):275-280.

PMID: 38916116 PMC: 11304751. DOI: 10.1089/gtmb.2023.0365.

References

Abdulhaq U, Daana M, Dor T, Fellig Y, Eylon S, Schuelke M . Nemaline body myopathy caused by a novel mutation in troponin T1 (TNNT1). Muscle Nerve. 2015; 53(4):564-9. DOI: 10.1002/mus.24885. View

Clayton J, McNamara E, Goullee H, Conijn S, Muthsam K, Musk G . Ovine congenital progressive muscular dystrophy (OCPMD) is a model of TNNT1 congenital myopathy. Acta Neuropathol Commun. 2020; 8(1):142. PMC: 7441672. DOI: 10.1186/s40478-020-01017-1. View

DAmico A, Fattori F, Fiorillo C, Paglietti M, Chiarini Testa M, Verardo M . 'Amish Nemaline Myopathy' in 2 Italian siblings harbouring a novel homozygous mutation in Troponin-I gene. Neuromuscul Disord. 2019; 29(10):766-770. DOI: 10.1016/j.nmd.2019.09.005. View

Dahlstedt A, Katz A, Wieringa B, Westerblad H . Is creatine kinase responsible for fatigue? Studies of isolated skeletal muscle deficient in creatine kinase. FASEB J. 2000; 14(7):982-90. DOI: 10.1096/fasebj.14.7.982. View

Fattahi Z, Kalhor Z, Fadaee M, Vazehan R, Parsimehr E, Abolhassani A . Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population. Clin Genet. 2016; 91(3):386-402. DOI: 10.1111/cge.12810. View

Fox M, Carson V, Feng H, Lawlor M, Gray J, Brigatti K . TNNT1 nemaline myopathy: natural history and therapeutic frontier. Hum Mol Genet. 2018; 27(18):3272-3282. PMC: 6121192. DOI: 10.1093/hmg/ddy233. View

Geraud J, Dieterich K, Rendu J, Uro Coste E, Dobrzynski M, Marcorelle P . Clinical phenotype and loss of the slow skeletal muscle troponin T in three new patients with recessive TNNT1 nemaline myopathy. J Med Genet. 2020; 58(9):602-608. PMC: 8394741. DOI: 10.1136/jmedgenet-2019-106714. View

Johnston J, Kelley R, Crawford T, Morton D, Agarwala R, Koch T . A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet. 2000; 67(4):814-21. PMC: 1287886. DOI: 10.1086/303089. View

Konersman C, Freyermuth F, Winder T, Lawlor M, Lagier-Tourenne C, Patel S . Novel autosomal dominant TNNT1 mutation causing nemaline myopathy. Mol Genet Genomic Med. 2017; 5(6):678-691. PMC: 5702563. DOI: 10.1002/mgg3.325. View

10.

Lee S, Eum J, Park S, Ki S, Hwang B, Kee Y . TNNT1 myopathy with novel compound heterozygous mutations. Neuromuscul Disord. 2022; 32(2):176-184. DOI: 10.1016/j.nmd.2021.12.003. View

11.

Marra J, Engelstad K, Ankala A, Tanji K, Dastgir J, De Vivo D . Identification of a novel nemaline myopathy-causing mutation in the troponin T1 (TNNT1) gene: a case outside of the old order Amish. Muscle Nerve. 2014; 51(5):767-72. DOI: 10.1002/mus.24528. View

12.

Mondal A, Jin J . Protein Structure-Function Relationship at Work: Learning from Myopathy Mutations of the Slow Skeletal Muscle Isoform of Troponin T. Front Physiol. 2016; 7:449. PMC: 5062619. DOI: 10.3389/fphys.2016.00449. View

13.

Pellerin D, Aykanat A, Ellezam B, Troiano E, Karamchandani J, Dicaire M . Novel Recessive TNNT1 Congenital Core-Rod Myopathy in French Canadians. Ann Neurol. 2020; 87(4):568-583. PMC: 7078025. DOI: 10.1002/ana.25685. View

14.

Pergande M, Motameny S, Ozdemir O, Kreutzer M, Wang H, Daimaguler H . The genomic and clinical landscape of fetal akinesia. Genet Med. 2019; 22(3):511-523. DOI: 10.1038/s41436-019-0680-1. View

15.

Petrucci A, Primiano G, Savarese M, Sancricca C, Udd B, Servidei S . Novel TNNT1 mutation and mild nemaline myopathy phenotype in an Italian patient. Neuromuscul Disord. 2021; 31(6):532-538. DOI: 10.1016/j.nmd.2021.03.001. View

16.

Sato T, Ito Y, Nagasawa T . Regulation of skeletal muscle protein degradation and synthesis by oral administration of lysine in rats. J Nutr Sci Vitaminol (Tokyo). 2014; 59(5):412-9. DOI: 10.3177/jnsv.59.412. View

17.

Streff H, Bi W, Colon A, Adesina A, Miyake C, Lalani S . Amish nemaline myopathy and dilated cardiomyopathy caused by a homozygous contiguous gene deletion of TNNT1 and TNNI3 in a Mennonite child. Eur J Med Genet. 2018; 62(11):103567. PMC: 7237049. DOI: 10.1016/j.ejmg.2018.11.001. View

18.

van der Pol W, Leijenaar J, Spliet W, Lavrijsen S, Jansen N, Braun K . Nemaline myopathy caused byTNNT1 mutations in a Dutch pedigree. Mol Genet Genomic Med. 2014; 2(2):134-7. PMC: 3960055. DOI: 10.1002/mgg3.52. View

19.

Wang G, Zhao D, Yan C, Lin P . Exon skipping caused by splicing mutation in TNNT1 nemaline myopathy. J Hum Genet. 2022; 68(2):97-101. DOI: 10.1038/s10038-022-01096-z. View

20.

Zambon A, Abel F, Linnane B, ORourke D, Phadke R, Sewry C . Troponin-T type 1 (TNNT1)-related nemaline myopathy: unique respiratory phenotype and muscle pathology findings. Neuromuscul Disord. 2022; 32(3):245-254. DOI: 10.1016/j.nmd.2022.01.014. View